Leila-Sophie Otten (Leila S Otten)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Atrial Fibrillation

Direct Oral Anticoagulants

Drug Administration

Ejection Fraction

Top Venues

British journal of cancer

Clinical and translational science

Acta ophthalmologica

European respiratory review : an official journal of the European Respiratory Society

This page only lists publications with an associated author ORCID identifier.

Publications

Judith L Gulikers, Leila-Sophie Otten, Lizza E L Hendriks, Kristien Winckers, Yvonne Henskens, Jenneke Leentjens, Michel M van den Heuvel, Rob Ter Heine, Sander Croes, Berber Piet, Robin M J M van Geel
Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer. British journal of cancer 131 (3) (2024)
Judith L Gulikers, Leila-Sophie Otten, Lizza E L Hendriks, Kristien Winckers, Yvonne Henskens, Jenneke Leentjens, Michel M van den Heuvel, Rob Ter Heine, Sander Croes, Berber Piet, Robin M J M van Geel
Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer. British journal of cancer 131 (3) (2024)
Judith L Gulikers, Leila-Sophie Otten, Lizza E L Hendriks, Kristien Winckers, Yvonne Henskens, Jenneke Leentjens, Michel M van den Heuvel, Rob Ter Heine, Sander Croes, Berber Piet, Robin M J M van Geel
Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer. British journal of cancer (2024)
Judith L Gulikers, Leila-Sophie Otten, Lizza E L Hendriks, Kristien Winckers, Yvonne Henskens, Jenneke Leentjens, Michel M van den Heuvel, Rob Ter Heine, Sander Croes, Berber Piet, Robin M J M van Geel
Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer. British journal of cancer 131 (3) (2024)
Leila-Sophie Otten, Berber Piet, Demy van den Haak, Robert D Schouten, Milou Schuurbiers, Sushil K Badrising, Emmy Boerrigter, Sjaak A Burgers, Rob Ter Heine, Michel M van den Heuvel
Prognostic Value of Nivolumab Clearance in Non-Small Cell Lung Cancer Patients for Survival Early in Treatment. Clinical pharmacokinetics (2023)
Demy A C van den Haak, Leila-Sophie Otten, Hans J P M Koenen, Ruben L Smeets, Berber Piet, Peter Pickkers, Matthijs Kox, Rob Ter Heine
Evidence-based rationale for low dose nivolumab in critically ill patients with sepsis-induced immunosuppression. Clinical and translational science (2023)
Leila-Sophie Otten, Berber Piet, Michel M van den Heuvel, Catia Marzolini, Robin M J M van Geel, Judith L Gulikers, David M Burger, Jenneke Leentjens, Rob Ter Heine
Practical recommendations to combine small-molecule inhibitors and direct oral anticoagulants in patients with nonsmall cell lung cancer. European respiratory review : an official journal of the European Respiratory Society 31 (164) (2022)
Leila-Sophie Otten, Madelon H Butterhoff-Terlingen, Verena C Mulder, Willemien Lagas-de Graaf, Angela M van der Hage-Lie, Paul D van der Linden
Severe epistaxis related to intravitreal bevacizumab. Acta ophthalmologica 98 (1) (2019)